| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SENS | Common Stock | Sale | $1,358 | -652 | -100% | $2.08 | 0 | 19 May 2021 | See footnote | F1, F2 |
| holding | SENS | Common Stock | 273,077 | 19 May 2021 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | This transaction was executed in multiple trades at prices ranging from $2.08 to $2.085, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F2 | Shares held directly by Delphi BioInvestments VIII, L.P. ("DBI VIII"). The Reporting Person is a managing member of Delphi Management Partners VIII, L.L.C. ("DMP"), the general partner of DBI VIII. As a managing member of DMP, the Reporting Person shares voting and investment power over the securities held by DBI VIII and may be deemed to have indirect beneficial ownership of such shares. The Reporting Person disclaims beneficial ownership of such securities held by DBI VIII, except to the extent of his proportionate pecuniary interest therein. |
| F3 | Represents a restricted stock unit ("RSU") grant on July 7, 2020. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in full on the earlier of the one year anniversary of the date of grant or the next annual stockholders meeting, subject to the reporting person's continuous service through such vesting date. |